Ishita Drugs and Industries Limited (ISHITADR.BO)
INR 86.0
(-0.69%)
INR 86.0
(-0.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 11.88 Million INR | -3.88% |
| 2022 | 9.62 Million INR | -19.7% |
| 2021 | 11.97 Million INR | -3.4% |
| 2020 | 12.31 Million INR | 33.59% |
| 2019 | 9.25 Million INR | 36.49% |
| 2018 | 6.79 Million INR | 20.82% |
| 2017 | 5.71 Million INR | 33.85% |
| 2016 | 4.41 Million INR | 13.94% |
| 2015 | 4.02 Million INR | -21.25% |
| 2014 | 4.83 Million INR | 17.54% |
| 2013 | 4.51 Million INR | -14.75% |
| 2012 | 4.59 Million INR | 10.4% |
| 2011 | 4.16 Million INR | -39.06% |
| 2010 | 6.83 Million INR | -6.46% |
| 2009 | 7.3 Million INR | 21.85% |
| 2008 | 5.99 Million INR | -3.18% |
| 2007 | 6.19 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.73 Million INR | -41.58% |
| 2023 Q4 | 2.93 Million INR | 28.74% |
| 2023 Q1 | 2.42 Million INR | -21.79% |
| 2023 Q2 | 3.14 Million INR | 29.5% |
| 2023 FY | - INR | -3.88% |
| 2023 Q3 | 2.27 Million INR | -27.49% |
| 2022 Q2 | 1.91 Million INR | -25.62% |
| 2022 Q3 | 1.86 Million INR | -2.56% |
| 2022 Q4 | 3.1 Million INR | 66.47% |
| 2022 FY | - INR | -19.7% |
| 2022 Q1 | 2.57 Million INR | -46.17% |
| 2021 Q4 | 4.77 Million INR | 88.26% |
| 2021 Q1 | 2.17 Million INR | -61.52% |
| 2021 Q2 | 2.28 Million INR | 5.11% |
| 2021 Q3 | 2.53 Million INR | 11.22% |
| 2021 FY | - INR | -3.4% |
| 2020 Q3 | 2.41 Million INR | -0.09% |
| 2020 FY | - INR | 33.59% |
| 2020 Q4 | 5.64 Million INR | 133.42% |
| 2020 Q2 | 2.41 Million INR | 41.76% |
| 2020 Q1 | 1.7 Million INR | -36.7% |
| 2019 FY | - INR | 36.49% |
| 2019 Q4 | 2.69 Million INR | 22.08% |
| 2019 Q3 | 2.2 Million INR | 4.39% |
| 2019 Q2 | 2.11 Million INR | 0.59% |
| 2019 Q1 | 2.1 Million INR | 0.63% |
| 2018 Q2 | 1.49 Million INR | 1.02% |
| 2018 Q4 | 2.08 Million INR | 28.66% |
| 2018 FY | - INR | 20.82% |
| 2018 Q1 | 1.47 Million INR | -39.76% |
| 2018 Q3 | 1.62 Million INR | 8.87% |
| 2017 Q2 | 1.04 Million INR | -11.89% |
| 2017 Q1 | 1.18 Million INR | -16.78% |
| 2017 FY | - INR | 33.85% |
| 2017 Q4 | 2.45 Million INR | 119.91% |
| 2017 Q3 | 1.11 Million INR | 7.01% |
| 2016 Q1 | 882 Thousand INR | -47.19% |
| 2016 FY | - INR | 13.94% |
| 2016 Q2 | 861 Thousand INR | -2.38% |
| 2016 Q4 | 1.42 Million INR | 13.86% |
| 2016 Q3 | 1.24 Million INR | 44.95% |
| 2015 FY | - INR | -21.25% |
| 2015 Q4 | 1.67 Million INR | 101.69% |
| 2015 Q3 | 828 Thousand INR | 80.94% |
| 2015 Q1 | 1.06 Million INR | 201.88% |
| 2015 Q2 | 457.6 Thousand INR | -57.19% |
| 2014 Q2 | 1.4 Million INR | 120.03% |
| 2014 Q1 | 639 Thousand INR | 279.76% |
| 2014 FY | - INR | 17.54% |
| 2014 Q4 | 354.11 Thousand INR | -81.67% |
| 2014 Q3 | 1.93 Million INR | 37.41% |
| 2013 Q3 | 717 Thousand INR | -48.97% |
| 2013 Q2 | 1.4 Million INR | -8.17% |
| 2013 Q4 | 168.26 Thousand INR | -76.53% |
| 2013 Q1 | 1.53 Million INR | -39.29% |
| 2013 FY | - INR | -14.75% |
| 2012 Q1 | 1.35 Million INR | -2.03% |
| 2012 Q4 | 2.52 Million INR | 42.05% |
| 2012 FY | - INR | 10.4% |
| 2012 Q3 | 1.77 Million INR | 4.48% |
| 2012 Q2 | 1.69 Million INR | 25.5% |
| 2011 FY | - INR | -39.06% |
| 2011 Q4 | 1.38 Million INR | 23.19% |
| 2011 Q3 | 1.12 Million INR | 0.0% |
| 2010 Q4 | 2.98 Million INR | 0.0% |
| 2010 FY | - INR | -6.46% |
| 2009 Q4 | 2.6 Million INR | 0.0% |
| 2009 FY | - INR | 21.85% |
| 2008 Q4 | 1.44 Million INR | 0.0% |
| 2008 FY | - INR | -3.18% |
| 2007 FY | - INR | 0.0% |
| 2007 Q4 | 1.92 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -1761.123% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -2.624% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 86.644% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 85.886% |
| Sunil Healthcare Limited | 93.07 Million INR | 87.228% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | 28.03% |
| MedPlus Health Services Limited | 3.94 Billion INR | 99.698% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 107.87% |
| Patidar Buildcon Limited | -5.52 Million INR | 315.128% |
| Roopa Industries Limited | 55.7 Million INR | 78.657% |
| Smruthi Organics Limited | 120.31 Million INR | 90.119% |
| Trident Lifeline Limited | 102.69 Million INR | 88.424% |
| PANJON LTD. | 4.08 Million INR | -190.731% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 109.643% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | 25.124% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 162.398% |
| Anuh Pharma Limited | 878.5 Million INR | 98.647% |
| Crestchem Limited | 30.33 Million INR | 60.81% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 209.891% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | 56.283% |
| Tyche Industries Limited | 128.2 Million INR | 90.727% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 96.944% |
| Trimurthi Limited | -2.47 Million INR | 579.643% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 94.511% |
| Norris Medicines Limited | -1.78 Million INR | 766.314% |
| Zenlabs Ethica Limited | 27.09 Million INR | 56.126% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 96.928% |
| ANG Lifesciences India Limited | 90.66 Million INR | 86.888% |
| Parmax Pharma Limited | 22.93 Million INR | 48.172% |
| Veerhealth Care Limited | 15.99 Million INR | 25.677% |
| Deccan Health Care Limited | 37.5 Million INR | 68.304% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 95.323% |
| Makers Laboratories Limited | 25.81 Million INR | 53.944% |
| Lactose (India) Limited | 201.22 Million INR | 94.092% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 112.361% |
| Zenith Healthcare Limited | 4.98 Million INR | -138.332% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 86.427% |
| Bacil Pharma Limited | -569.32 Thousand INR | 2188.105% |
| PRAVEG LIMITED | 321.43 Million INR | 96.302% |
| Denis Chem Lab Limited | 224.84 Million INR | 94.713% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 98.053% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 96.854% |
| Colinz Laboratories Limited | 5.42 Million INR | -119.013% |
| Godavari Drugs Limited | 134.62 Million INR | 91.17% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 3028.079% |
| Zenotech Laboratories Limited | 172.64 Million INR | 93.114% |
| Panchsheel Organics Limited | 189.36 Million INR | 93.722% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 97.351% |
| Vivanza Biosciences Limited | 11.2 Million INR | -6.105% |
| Phaarmasia Limited | -1.58 Million INR | 851.454% |
| Sastasundar Ventures Limited | -203.51 Million INR | 105.841% |
| Medi-Caps Limited | 4.77 Million INR | -149.172% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 537.059% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 98.569% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 93.031% |
| Mercury Laboratories Limited | 101.18 Million INR | 88.252% |
| Gennex Laboratories Limited | 219.35 Million INR | 94.581% |
| BDH Industries Limited | 124.27 Million INR | 90.434% |
| Coral Laboratories Limited | 227.07 Million INR | 94.765% |
| Concord Drugs Limited | 40.52 Million INR | 70.661% |
| Bharat Parenterals Limited | 265.74 Million INR | 95.526% |
| Beryl Drugs Limited | 26.63 Million INR | 55.374% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 136.715% |
| Evoq Remedies Limited | 6.18 Million INR | -92.115% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 85.61% |
| Transchem Limited | 56.61 Million INR | 79.001% |
| Parnax Lab Limited | 243.59 Million INR | 95.12% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 73.467% |
| Kerala Ayurveda Limited | 70.78 Million INR | 83.206% |
| Cian Healthcare Limited | 122.56 Million INR | 90.301% |
| Trinity League India Limited | -26.25 Million INR | 145.282% |
| Syschem (India) Limited | 70.4 Million INR | 83.114% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 238.668% |
| Natural Capsules Limited | 219.9 Million INR | 94.594% |
| Auro Laboratories Limited | 121.73 Million INR | 90.235% |